Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers
暂无分享,去创建一个
[1] C. Dinarello,et al. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha , 1988, The Journal of experimental medicine.
[2] S. Stevenson,et al. Evaluation of biocompatible osteoconductive polymer as an orthopedic implant in dogs. , 1992, Journal of the American Veterinary Medical Association.
[3] N V Katre,et al. Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. , 1990, Journal of immunology.
[4] A. Pennings,et al. Porous polymer implant for repair of meniscal lesions: a preliminary study in dogs. , 1991, Biomaterials.
[5] J. Scales,et al. Incidence of metal sensitivity in patients with total joint replacements. , 1975, British medical journal.
[6] A. Dalmasso,et al. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. , 1977, The Journal of clinical investigation.
[7] P. Doty,et al. STUDIES ON SYNTHETIC POLYPEPTIDE ANTIGENS. XI. THE ANTIGENICITY OF OPTICALLY ISOMERIC SYNTHETIC POLYPEPTIDES. , 1964, The Journal of biological chemistry.
[8] R. Niven,et al. Pulmonary absorption of polyethylene glycolated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) , 1994 .
[9] C. Sledge,et al. Biochemical and histological evaluation of the synovial-like tissue around failed (loose) total joint replacement prostheses in human subjects and a canine model. , 1990, Biomaterials.
[10] D. Rahman,et al. Biodegradable microparticles as controlled release antigen delivery systems. , 1991, Immunology.
[11] J. Davey,et al. Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.
[12] F. Balkwill,et al. The cytokine network. , 1989, Immunology today.
[13] W. Park,et al. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. , 1995, Biomaterials.
[14] E. Macewen,et al. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma. , 1992, Journal of veterinary internal medicine.
[15] G. Ciapetti,et al. Production of prostacyclin and fibrinolysis modulators by endothelial cells cultured in the presence of polyethylene terephthalate. , 1993, Journal of biomedical materials research.
[16] T. Balstad,et al. Generation and removal of anaphylatoxins during hemofiltration with five different membranes. , 1988, Blood purification.
[17] A. Jayakrishnan,et al. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. , 1996, Biomaterials.
[18] K. Bendtzen,et al. Autoantibodies to cytokines--friends or foes? , 1990, Immunology today.
[19] Brown Jm. Polyurethane and silicone: myths and misconceptions. , 1995 .
[20] Y. Tsutsumi,et al. Chemical Modification of Natural Human Tumor Necrosis Factor‐α with Polyethylene Glycol Increases Its Anti‐tumor Potency , 1994, Japanese journal of cancer research : Gann.
[21] A. Swanson,et al. Long-term silicone implant arthroplasty. Implications of animal and human autopsy findings. , 1983, JAMA.
[22] D. Williams,et al. Biocompatibility of tissue analogs , 1985 .
[23] R. Goldblum,et al. Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts , 1992, The Lancet.
[24] J. Soothill,et al. Time sequence of acute phase reactive proteins following surgical trauma. , 1966, Clinica chimica acta; international journal of clinical chemistry.
[25] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[26] J. Kopecek,et al. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. , 1987, British Journal of Cancer.
[27] K. Ulbrich,et al. Effect of the chemical structure of N- (2- hydroxypropyl) methacrylajnide copolymers on their ability to induce antibody formation in inbred strains of mice , 1984 .
[28] K. Tracey,et al. Peptide Regulatory Factors CACHECTIN/TUMOUR NECROSIS FACTOR , 1989, The Lancet.
[29] S. Davis,et al. The immunogenicity of a model protein entrapped in poly(lactide-co-glycolide) microparticles prepared by a novel phase separation technique , 1994 .
[30] J. Anderson,et al. Human monocyte/macrophage activation and interleukin 1 generation by biomedical polymers. , 1988, Journal of biomedical materials research.
[31] F. Davis,et al. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. , 1977, The Journal of biological chemistry.
[32] S. Mizel,et al. Interleukin 1, a potential regulator of fibroblast proliferation. , 1982, Journal of immunology.
[33] T. Hirano,et al. Molecular regulation of B lymphocyte response. , 1988, Annual review of immunology.
[34] E. Kaplan,et al. Silicone-Induced Human Adjuvant Disease? , 1983, Annals of plastic surgery.
[35] A. Sehon. Carl Prausnitz Memorial Lecture. Suppression of antibody responses by chemically modified antigens. , 1991, International archives of allergy and applied immunology.
[36] Y. Tsutsumi,et al. Polyethylene glycol modification of interleukin-6 enhances its thrombopoietic activity , 1995 .
[37] V. Šubr,et al. Immunogenicity of Protein-N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates in A/J and B10 Mice , 1990 .
[38] T. Watanabe,et al. Fever and acute phase response induced in rabbits by human recombinant interferon‐gamma. , 1987, The Journal of physiology.
[39] T. Matsuda,et al. Novel photoreactive surface modification technology for fabricated devices. , 1990, ASAIO transactions.
[40] K. Ulbrich,et al. Biocompatibility of Biopolymers , 1992 .
[41] J. M. Harris,et al. Poly(Ethylene Glycol) Chemistry , 1992 .
[42] I. Feuerstein,et al. Adherent platelet morphology on adsorbed fibrinogen: effects of protein incubation time and albumin addition. , 1994, Journal of biomedical materials research.
[43] B. Říhová,et al. Immunological problems of polymer-bound drugs. , 1985, Critical reviews in therapeutic drug carrier systems.
[44] H. Maeda,et al. Toxicity of Bilirubin and Detoxification by PEG-Bilirubin Oxidase Conjugate , 1992 .
[45] R. Smith,et al. Silicone synovitis of the wrist. , 1985, The Journal of hand surgery.
[46] M. Alonso,et al. Novel Approaches to Controlled-Release Antigen Delivery , 1994, International Journal of Technology Assessment in Health Care.
[47] E. Ruckenstein,et al. Preparation and characterization of thin film surface coatings for biological environments. , 1986, Biomaterials.
[48] C. A. van Blitterswijk,et al. In vitro biocompatibility testing of polylactides Part I Proliferation of different cell types , 1992 .
[49] R Weissleder,et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.
[50] K. Matsushima,et al. There is more than one interleukin 1. , 1986, Immunology today.
[51] J V Castell,et al. Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.
[52] F. Schué,et al. Modification of the biocompatible and haemocompatible properties of polymer substrates by plasma-deposited fluorocarbon coatings. , 1992, Biomaterials.
[53] I. Yada,et al. Hematological problems during the use of cardiac assist devices: clinical experiences in Japan. , 2008, Artificial organs.
[54] M. Hashida,et al. In vitro cytotoxicity of macromolecules in different cell culture systems , 1995 .
[55] P. Malchesky,et al. Evaluation of a relationship between polymer bulk hydroxyl and surface oxygen content and in vitro serum-material interaction. , 1993, Journal of biomedical materials research.
[56] M. Barbosa,et al. Differential effects of eight metal ions on lymphocyte differentiation antigens in vitro. , 1990, Journal of biomedical materials research.
[57] K. P. Rao,et al. In vivo biocompatibility of collagen-poly(hydroxyethyl methacrylate) hydrogels. , 1990, Biomaterials.
[58] T. Shimoyama,et al. In Vitro Evaluation of a Relationship Between Human Serumor Plasma-Material Interaction and Polymer Bulk Hydroxyl and Surface Oxygen Content , 1993, ASAIO journal.
[59] R. Stroud,et al. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. , 1976, Immunochemistry.
[60] W. Hörl,et al. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. , 1986, Clinical nephrology.
[61] V. Vetvicka,et al. Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. , 1988, Clinical immunology and immunopathology.
[62] E. Ritz,et al. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. , 1988, Kidney international.
[63] B. Descamps-Latscha,et al. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. , 1985, Kidney international.
[64] B. Beutler,et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 , 1986, The Journal of experimental medicine.
[65] B. Říhová,et al. Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugates☆ , 1985 .
[66] J. Hubbell,et al. The short-term blood biocompatibility of poly(hydroxyethyl methacrylate-co-methyl methacrylate) in an in vitro flow system measured by digital videomicroscopy. , 1989, Journal of biomaterials science. Polymer edition.
[67] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.
[68] S. Jimenez,et al. Systemic sclerosis after augmentation mammoplasty with silicone implants. , 1989, Annals of internal medicine.
[69] C. Doyle. Advances in biomaterials: Lee SM editor 1987 Volume 1. Lancaster, PA: Technomics Inc. 286pp. $65 , 1987 .
[70] J. Kopeček. Synthesis of Tailor-Made Soluble Polymeric Drug Carriers , 1984 .
[71] D. Roccatello,et al. Serum and intracellular detection of cytokines in patients undergoing chronic hemodialysis. , 2008, Artificial organs.
[72] J. Kopeček,et al. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. , 1988, British Journal of Cancer.
[73] R. Pabst,et al. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? , 1990, Immunology today.
[74] H. Colten,et al. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.
[75] F. Ashley. A NEW TYPE OF BREAST PROSTHESIS: Preliminary Report , 1970, Plastic and reconstructive surgery.
[76] J. A. Hubbell,et al. Photo-crosslinked copolymers of 2-hydroxyethyl methacrylate, poly(ethylene glycol) tetra-acrylate and ethylene dimethacrylate for improving biocompatibility of biosensors. , 1995, Biomaterials.
[77] T. Kircher. Silicone lymphadenopathy: a complication of silicone elastomer finger joint prostheses. , 1980, Human pathology.
[78] W. Laird,et al. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[79] F. Ashley. FURTHER STUDIES ON THE NATURAL‐Y BREAST PROSTHESIS , 1972, Plastic and Reconstructive Surgery.
[80] O. Reikerås,et al. Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. , 1992, The European journal of surgery = Acta chirurgica.
[81] T. Lint,et al. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations. , 1975, Journal of immunology.
[82] A. Pizzoferrato,et al. Numerical and functional modifications in platelets induced by polyester coated by a hydrophilic polymer. , 1993, Biomaterials.
[83] S. Fukushima,et al. Control of drug release with a combination of prodrug and polymer matrix: antitumor activity and release profiles of 2',3'-diacyl-5-fluoro-2'-deoxyuridine from poly(3-hydroxybutyrate) microspheres. , 1992, Journal of pharmaceutical sciences.
[84] I. Pastan,et al. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin. , 1993, Cancer research.
[85] R. Gurny,et al. Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil. , 1994, Journal of biomedical materials research.
[86] W. van Oeveren,et al. Platelet Function Analysis After In Vitro Treatment with Hemostasis-Affecting Components , 1995, Seminars in Thrombosis & Hemostasis.
[87] N. L. Krinick,et al. Targetable photoactivalable drugs. 3. In vitro efficacy of polymer bound chlorin e6 toward human hepatocarcinoma cell line (PLC/PRF/5) targeted with galactosamine and to mouse splenocytes targeted with anti-Thy 1.2 antibodies , 1993 .
[88] C. Price,et al. Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein. , 1987, Journal of immunological methods.
[89] L. Henderson,et al. Biocompatibility of artificial organs: an overview. , 1987, Blood purification.
[90] K. James. Interactions between cytokines and α2-macroglobulin , 1990 .
[91] I. Colombo,et al. Investigation of surface properties of some polymers by a thermodynamic and mechanical approach: possibility of predicting mucoadhesion and biocompatibility. , 1994, Biomaterials.
[92] M. Nucci,et al. The therapeutic value of poly(ethylene glycol)-modified proteins , 1991 .
[93] L. Henderson,et al. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers. , 1987, Artificial organs.
[94] Hashida Mitsuru,et al. Pharmacokinetics of succinylated proteins and dextran sulfate in mice : implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors , 1994 .
[95] R. Faith,et al. Effects of stress on the immune system. , 1990, Immunology today.
[96] J. Kopeček,et al. Soluble synthetic polymers as potential drug carriers , 1984 .
[97] H De Geest,et al. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. , 1995, Atherosclerosis.
[98] Y. Inada,et al. Review : Polyethylene Glycol(PEG)-Protein Conjugates: Application to Biomedical and Biotechnological Processes , 1990 .
[99] D. Louria,et al. THE EFFECTS OF CORTISONE ON EXPERIMENTAL FUNGUS INFECTIONS * , 1960, Annals of the New York Academy of Sciences.
[100] B. Stadler,et al. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). , 1981, Journal of immunology.
[101] D. Williams,et al. Immune response in biocompatibility. , 1992, Biomaterials.
[102] R. Tamargo,et al. Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain. , 1989, Selective cancer therapeutics.
[103] P. Lansdorp,et al. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[104] S. Akira,et al. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF) , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[105] J. Remon,et al. Immunogenicity of poly-D-lysine, a potential polymeric drug carrier , 1994 .
[106] P. Bullough,et al. Synovial and osseous inflammation in failed silicone-rubber prostheses. , 1982, The Journal of bone and joint surgery. American volume.
[107] C. Peimer,et al. Reactive synovitis after silicone arthroplasty. , 1986, The Journal of hand surgery.
[108] A. Sehon. Suppression of IgE antibody responses with tolerogenic conjugates of allergens and haptens. , 1982, Progress in allergy.
[109] K. Tracey,et al. Cachectin/tumour necrosis factor. , 1989, Lancet.
[110] F. Wiese,et al. Chemical modification of cellulosic membranes and their blood compatibility. , 2008, Artificial organs.
[111] A. Abuchowski,et al. The clinical efficacy of poly(ethylene glycol)-modified proteins , 1990 .
[112] H. Northoff,et al. Discrimination of hepatocyte‐stimulating activity from human recombinant tumor necrosis factor α , 1987, European journal of immunology.
[113] M. Robson,et al. Experimental demonstration of the immunogenicity of silicone-protein complexes. , 1987, Journal of biomedical materials research.
[114] G. Weissmann,et al. Tumor necrosis factor provokes superoxide anion generation from neutrophils. , 1986, Biochemical and biophysical research communications.
[115] M. Hershfield,et al. Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[116] Larry V. McIntire,et al. Leucocyte adhesion under flow conditions: principles important in tissue engineering. , 1996, Biomaterials.
[117] B. Říhová,et al. The Activity of Complement in the Presence of N-(2-hydroxypropyl)methacrylamide Copolymers , 1986 .
[118] D. J. Harrison,et al. Preliminary in vivo biocompatibility studies on perfluorosulphonic acid polymer membranes for biosensor applications. , 1991, Biomaterials.
[119] A. Irvine,et al. Polyethylene glycol (PEG)-modified granulocyte-macrophage colony-stimulating factor (GM-CSF) with conserved biological activity. , 1992, Experimental hematology.
[120] B. Gander,et al. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. , 1995, Vaccine.
[121] J. Anderson,et al. Human monocyte/macrophage adhesion and cytokine production on surface-modified poly(tetrafluoroethylene/hexafluoropropylene) polymers with and without protein preadsorption. , 1995, Journal of biomedical materials research.
[122] C. V. van Blitterswijk,et al. Interfacial behavior of PEO/PBT copolymers (Polyactive) in a calvarial system: an in vitro study. , 1994, Journal of biomedical materials research.
[123] R. Tompkins,et al. Long‐Term in Vitro Function of Adult Hepatocytes in a Collagen Sandwich Configuration , 1991, Biotechnology progress.
[124] J. Kopeček,et al. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. , 1987, Journal of biomedical materials research.
[125] L. Old,et al. Tumor necrosis factor (TNF). , 1985, Science.
[126] F. Davis,et al. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. , 1977, The Journal of biological chemistry.
[127] J. Moragas,et al. Lymphocyte transformation test in allergic contact nickel dermatitis , 1975, The British journal of dermatology.
[128] D. Springfield,et al. Pseudotumor of the arm associated with rupture of silicone-gel breast prostheses. Report of two cases. , 1983, The Journal of bone and joint surgery. American volume.
[129] S. Akira,et al. Biological and clinical aspects of interleukin 6. , 1990, Immunology today.
[130] A. Koj,et al. The Acute-phase response to injury and infection : the roles of interleukin 1 and other mediators , 1985 .
[131] J. Oleffe,et al. Methylmethacrylate hypersensitivity in a patient with cemented endoprosthesis. A case report. , 1978, Acta orthopaedica Scandinavica.
[132] W. Goebel,et al. Reactions to acrylic resin dental prostheses. , 1980, The Journal of prosthetic dentistry.
[133] E. Balazs,et al. Hylan gel biomaterial: dermal and immunologic compatibility. , 1993, Journal of biomedical materials research.
[134] T. Luger,et al. Blood-membrane interaction in hemodialysis leads to increased cytokine production. , 1987, Kidney international.
[135] W. Shen,et al. Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[136] R. Nakamura,et al. Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications. , 1976, American journal of clinical pathology.
[137] K. Ulbrich,et al. Antibody-targeted cyclosporin A , 1992 .
[138] R. Langer,et al. Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology. , 1990, Journal of biomedical materials research.
[139] R. Duncan,et al. Biological Evaluation of Soluble Synthetic Polymers as Drug Carriers , 1984 .
[140] R. Gurny,et al. Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery system. , 1989, Journal of biomedical materials research.
[141] R. Ward,et al. Response of complement and neutrophils to hydrophilized synthetic membranes. , 1988, ASAIO transactions.
[142] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[143] R. Ross,et al. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. , 1976, The American journal of pathology.
[144] M. Kazatchkine,et al. The role of naturally-occurring antibodies against man-made materials in biocompatibility , 1990 .
[145] K. Ulbrich,et al. Immunogenicity of N‐(2‐hydroxypropyl) methacrylamide copolymers , 1985 .
[146] L. Pulliam,et al. Multiple biological activities of a partially purified leukocytic endogenous mediator. , 1973, The American journal of physiology.
[147] D. Falkenhagen,et al. Biocompatibility--a system approach. , 1989, Advances in experimental medicine and biology.
[148] M. Loos,et al. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4. , 1976, Immunochemistry.
[149] Low Friction Hydrophilic Surface for Medical Devices , 1990 .
[150] T. Matsuda,et al. Surface coating of hydrophilic-hydrophobic block co-polymers on a poly(acrylonitrile) haemodialyser reduces platelet adhesion and its transmembrane stimulation. , 1994, Biomaterials.
[151] I. Kushner. THE PHENOMENON OF THE ACUTE PHASE RESPONSE * , 1982, Annals of the New York Academy of Sciences.
[152] J. Anderson,et al. Biomaterial biocompatibility and the macrophage. , 1984, Biomaterials.
[153] F. H. van der Veen,et al. Studies on a new radiopaque polymeric biomaterial. , 1994, Biomaterials.
[154] K. Ulbrich,et al. Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. , 1989, Biomaterials.
[155] J. Gauldie,et al. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. , 1990, Molecular biology & medicine.
[156] K. Ulbrich,et al. Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycin , 1989 .
[157] M. Doni,et al. METHYLMETHACRYLATE HYPERSENSITIVITY IN A PATIENT WITH CEMENTED ENDOPROSTHESIS , 1978 .
[158] N Kossovsky,et al. Biocompatibility of Silicone Implants , 1983, Annals of plastic surgery.
[159] D. Fearon,et al. Biocompatibility of dialysis membranes: effects of chronic complement activation. , 1984, Kidney international.
[160] J. Bauer,et al. Regulation of interleukin‐6 receptor expression in human monocytes and hepatocytes , 1989, FEBS letters.
[161] J. Vacík,et al. Experimental implantation of hydrogel into the bone. , 1988, Journal of biomedical materials research.
[162] J. Vienken,et al. Considerations on developmental aspects of biocompatible dialysis membranes. , 1995, Artificial organs.
[163] J. Anderson,et al. A hydrophilic plasma polymerized film composite with potential application as an interface for biomaterials. , 1990, Journal of biomedical materials research.
[164] A. Lanzavecchia,et al. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. , 1985, Journal of immunology.
[165] P. Christel,et al. Plasma protein adsorption to artificial ligament fibers. , 1995, Journal of biomedical materials research.
[166] J. Uhr,et al. Immunotoxins: magic bullets or misguided missiles? , 1993, Trends in pharmacological sciences.
[167] N L Burnham,et al. Polymers for delivering peptides and proteins. , 1994, American journal of hospital pharmacy.
[168] C. M. Agrawal,et al. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.
[169] J. B. Liesch,et al. Differential production of interleukin 1 on the surface of biomaterials. , 1990, Archives of surgery.
[170] D. Magilligan,et al. Fate of a second porcine bioprosthetic valve. , 1983, The Journal of thoracic and cardiovascular surgery.